DJIA 16,832.65 56.22 0.34%
NASDAQ 4,753.81 -27.45 -0.57%
S&P 500 1,982.56 -4.49 -0.23%
market minute promo

Seattle Genetics (NASDAQ: SGEN)

38.51 -1.78 (-4.42%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

SGEN $38.51 -4.42%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $41.88
Previous Close $40.29
Daily Range $37.26 - $41.88
52-Week Range $30.05 - $52.33
Market Cap $4.8B
P/E Ratio -45.27
Dividend (Yield) $0.00 (0.0%)
Volume 678,463
Average Daily Volume 1,288,991
Current FY EPS -$0.95




Drug Makers

Seattle Genetics (SGEN) Description

A biotechnology company, which develops monoclonal antibody-based therapies for the treatment of cancer and autoimmune diseases. Website:

News & Commentary Rss Feed

Why Biotech Took a Beating Today

What goes up must come down.

3 Biotech Stocks Loved by Portfolio Managers Now

Seattle Genetics: 3 Reasons Why I Like This Midcap Biotech

Water-Logged And Getting Wetter Stock Of The Day: Seattle Genetics (SGEN)

Interesting SGEN Put And Call Options For November 20th

3 Mid-Cap Biotechs We're Excited About

Our healthcare contributors think you should add these mid-cap biotechs to your watch list.

American Eagle Outfitters, Sears And Others That Insiders Have Been Buying

Insiders Are Buying Barnes & Noble

Insiders Are Buying Barnes & Noble

Global Imbalances and the Chinese Economy - John Mauldin

See More SGEN News...

SGEN's Top Competitors

SGEN $38.51 (-4.42%)
Current stock: SGEN
AMGN $141.74 (-1.43%)
Current stock: AMGN
GILD $97.50 (-1.77%)
Current stock: GILD
BIIB $276.52 (-3.50%)
Current stock: BIIB